InvestorsObserver
×
News Home

How Will the Market React to Evogene Ltd (EVGN) Stock Getting a Bullish Rating

Tuesday, January 26, 2021 10:13 AM | InvestorsObserver Analysts

Mentioned in this article

How Will the Market React to Evogene Ltd (EVGN) Stock Getting a Bullish Rating

The market has been high on Evogene Ltd (EVGN) stock recently. EVGN gets a Bullish score from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bullish
Evogene Ltd has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on EVGN!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.

As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.

Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.

InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.

The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With EVGN Stock Today?

Evogene Ltd (EVGN) stock is higher by 11.52% while the S&P 500 is down -0.02% as of 10:11 AM on Tuesday, Jan 26. EVGN has gained $0.76 from the previous closing price of $6.60 on volume of 806,718 shares. Over the past year the S&P 500 is up 18.83% while EVGN has gained 371.79%. EVGN lost -$0.81 per share in the over the last 12 months.

To see the top 5 stocks in the Biotechnology industry click here.

More About Evogene Ltd

Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules and genetic elements as the core components for such products. It holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.

Click Here to get the full Stock Score Report on Evogene Ltd (EVGN) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App